Danaher Co. (NYSE:DHR) Chairman Mitchell P. Rales purchased 1,900 shares of the business’s stock in a transaction dated Friday, May 10th. The shares were purchased at an average price of $130.78 per share, for a total transaction of $248,482.00. The purchase was disclosed in a legal filing with the SEC, which is available at this link.

Shares of DHR stock opened at $130.75 on Thursday. Danaher Co. has a 12-month low of $94.59 and a 12-month high of $134.67. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.74 and a current ratio of 2.18. The company has a market capitalization of $92.68 billion, a P/E ratio of 28.93, a P/E/G ratio of 2.50 and a beta of 1.02.

Danaher (NYSE:DHR) last issued its earnings results on Thursday, April 18th. The conglomerate reported $1.07 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.01 by $0.06. Danaher had a net margin of 12.04% and a return on equity of 11.61%. The company had revenue of $4.88 billion for the quarter, compared to analysts’ expectations of $4.80 billion. During the same quarter last year, the company posted $0.99 earnings per share. The firm’s quarterly revenue was up 3.9% on a year-over-year basis. As a group, equities analysts predict that Danaher Co. will post 4.77 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be given a $0.17 dividend. The ex-dividend date of this dividend is Thursday, June 27th. This represents a $0.68 annualized dividend and a yield of 0.52%. Danaher’s payout ratio is presently 15.04%.

DHR has been the topic of a number of recent analyst reports. Janney Montgomery Scott increased their price target on shares of Danaher from $136.00 to $174.00 and gave the company a “buy” rating in a report on Wednesday, April 17th. Jefferies Financial Group increased their price target on shares of Danaher to $140.00 and gave the company a “buy” rating in a report on Tuesday, February 26th. JPMorgan Chase & Co. reiterated an “overweight” rating and set a $140.00 price target on shares of Danaher in a report on Monday, March 4th. Zacks Investment Research upgraded shares of Danaher from a “sell” rating to a “hold” rating in a report on Monday, May 6th. Finally, Needham & Company LLC restated a “buy” rating and issued a $138.00 target price (up previously from $114.00) on shares of Danaher in a report on Thursday, February 28th. Two research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. Danaher presently has a consensus rating of “Buy” and an average target price of $131.75.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in DHR. Laurel Wealth Advisors LLC bought a new position in Danaher in the fourth quarter worth approximately $27,000. CX Institutional raised its position in Danaher by 188.7% in the first quarter. CX Institutional now owns 205 shares of the conglomerate’s stock worth $27,000 after acquiring an additional 134 shares during the period. Hanson McClain Inc. raised its position in Danaher by 852.9% in the fourth quarter. Hanson McClain Inc. now owns 324 shares of the conglomerate’s stock worth $33,000 after acquiring an additional 290 shares during the period. Executive Wealth Management LLC bought a new position in Danaher in the fourth quarter worth approximately $39,000. Finally, Ruggie Capital Group bought a new position in Danaher in the fourth quarter worth approximately $40,000. Institutional investors and hedge funds own 76.98% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Danaher Co. (DHR) Chairman Acquires $248,482.00 in Stock” was originally posted by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this story on another domain, it was illegally copied and republished in violation of international copyright and trademark laws. The legal version of this story can be viewed at https://theolympiareport.com/2019/05/16/danaher-co-dhr-chairman-acquires-248482-00-in-stock.html.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

Featured Article: Is a Roth IRA right for you?

Insider Buying and Selling by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.